يعرض 1 - 10 نتائج من 751 نتيجة بحث عن '"T Yilmaz"', وقت الاستعلام: 1.64s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
  4. 4
  5. 5
    دورية أكاديمية

    المصدر: Medical Herald of the South of Russia; Том 12, № 4 (2021); 27-33 ; Медицинский вестник Юга России; Том 12, № 4 (2021); 27-33 ; 2618-7876 ; 2219-8075 ; 10.21886/2219-8075-2021-12-4

    وصف الملف: application/pdf

    العلاقة: https://www.medicalherald.ru/jour/article/view/1427/853Test; https://www.medicalherald.ru/jour/article/downloadSuppFile/1427/518Test; https://www.medicalherald.ru/jour/article/downloadSuppFile/1427/519Test; https://www.medicalherald.ru/jour/article/downloadSuppFile/1427/520Test; Дедов И.И., Шестакова М.В., Майоров А.Ю., Викулова О.К., Галстян Г.Р., и др. «Алгоритмы специализированной медицинской помощи больным сахарным диабетом». Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова 9-й выпуск. Сахарный диабет. 2019; 22(1S1):1-144. DOI:10.14341/DM221S1; Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm — 2020 executive summary. Endocr Pract. 2020; 26(1):107-139. DOI:10.4158/CS-2019-0472.; Zhou J, Massey S, Story D, Li L. Metformin: An Old Drug with New Applications. Int J Mol Sci. 2018; 19(10):2863. DOI:10.3390/ijms19102863.; Bankura B, Das M, Pattanayak A, Adhikary B, Bhattacharjee R, et al. Inter-patient Variability in Clinical Efficacy of Metformin in Type 2 Diabetes MellitusPatients in West Bengal, India. Journal of Metabolic Syndrome. 2016;(5):2. DOI:10.4172/2167-0943.1000198.; Waterham HR, Ferdinandusse S, Wanders RJ. Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta. 2016; 1863(5):922-33. DOI:10.1016/j.bbamcr.2015.11.015.; Christofides A, Konstantinidou E, Jani C, Boussiotis VA. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metabolism. 2021; 114:154338. DOI:10.1016/j.metabol.2020.154338.; Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications — a review. Nutr J. 2014; 13:17. DOI:10.1186/1475-2891-13-17.; Yahaya TO, Salisu TF. A Review of Type 2 Diabetes Mellitus Predisposing Genes. Curr Diabetes Rev. 2019; 16(1):52-61. DOI:10.2174/1573399815666181204145806.; Кононенко И.В., Майоров А.Ю., Кокшарова Е.О., Шестакова М.В. Фармакогенетика сахароснижающих препаратов. Сахарный диабет. 2015; 18(4):28-34. DOI:10.14341/DM7681; Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest. 1998; 101(6):1354-61. DOI:10.1172/JCI1235.; Sarhangi N, Sharifi F, Hashemian L, Hassani Doabsari M, Heshmatzad K, et al. PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis. Sci Rep. 2020; 10(1):12764. DOI:10.1038/s41598-020-69363-7.; Groop L, Pociot F. Genetics of diabetes — are we missing the genes or the disease? Mol Cell Endocrinol. 2014; 382(1):726- 739. DOI:10.1016/j.mce.2013.04.002.; Leońska-Duniec A, Ahmetov II, Zmijewski P. Genetic variants influencing effectiveness of exercise training programmes in obesity — an overview of human studies. Biol Sport. 2016; 33(3):207-14. DOI:10.5604/20831862.1201052.; Castro GV, Latorre AFS, Korndorfer FP, de Carlos Back LK, Lofgren SE. The Impact of Variants in Four Genes: MC4R, FTO, PPARG and PPARGC1A in Overweight and Obesity in a Large Sample of the Brazilian Population. Biochem Genet. 2021; 59(6):1666-1679. DOI:10.1007/s10528-021-10079-2.; Bordoni L, Marchegiani F, Piangerelli M, Napolioni V, Gabbianelli R. Obesity-related genetic polymorphisms and adiposity indices in a young Italian population. IUBMB Life. 2017; 69(2):108-115. DOI:10.1002/iub.1596.; Wang X, Liu J, Ouyang Y, Fang M, Gao H, Liu L. The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese population. PLoS One. 2013; 8(8):e71985. DOI:10.1371/journal.pone.0071985.; Rodrigues APS, Rosa LPS, Silveira EA. PPARG2 Pro12Ala polymorphism influences body composition changes in severely obese patients consuming extra virgin olive oil: a randomized clinical trial. Nutr Metab (Lond). 2018; 15:52. DOI:10.1186/s12986-018-0289-4.; Chmurzynska A, Muzsik A, Krzyżanowska-Jankowska P, Mądry E, Walkowiak J, Bajerska J. PPARG and FTO polymorphism can modulate the outcomes of a central European diet and a Mediterranean diet in centrally obese postmenopausal women. Nutr Res. 2019; 69:94-100. DOI:10.1016/j.nutres.2019.08.005.; Matsuo T, Nakata Y, Katayama Y, Iemitsu M, Maeda S, et al. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring). 2009; 17(10):1924-31. DOI:10.1038/oby.2009.199.; Pearson ER. Diabetes: Is There a Future for Pharmacogenomics Guided Treatment? Clin Pharmacol Ther. 2019; 106(2):329-337. DOI:10.1002/cpt.1484.; Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, et al. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2007; 50(12):2451-60. DOI:10.1007/s00125-007-0826-6.; Masud S, Ye S; SAS Group. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet. 2003; 40(10):773-80. DOI:10.1136/jmg.40.10.773.; https://www.medicalherald.ru/jour/article/view/1427Test

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: E. Cerulli Irelli, E. Cocchi, G. Ramantani, A. Morano, A. Riva, R.H. Caraballo, L. Giuliano, T. Yilmaz, E. Panagiotakaki, F.F. Operto, B. Gonzalez Giraldez, S. Balestrini, K. Silvennoinen, S. Casciato, M. Comajuan, F. Fortunato, A.T. Giallonardo, R. Gamirova, A. Coppola, G. Di Gennaro, A. Labate, V. Sofia, G.J. Kluger, A. Gambardella, D. Kasteleijn-Nolst Trenite, B. Baykan, S.M. Sisodiya, A. Arzimanoglou, P. Striano, C.D.B.G. Fisco, S. Meletti, N. Liukshina, T. Tomenko, G. Gobbi, D. Buti, S. Casellato, S. Striano, T. Messana, L. Giordano, E. Ferlazzo, A. Vignoli, M. Viri, I. Bagnasco, N. Bebek, G. Altıokka-Uzun

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37021337; info:eu-repo/semantics/altIdentifier/wos/WOS:000974144800001; volume:64; issue:6; firstpage:e105; lastpage:e111; numberofpages:7; journal:EPILEPSIA; https://hdl.handle.net/2434/1002059Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85153755637

  8. 8
  9. 9
  10. 10